Evidence map›Paper›PMID 30288531›Full record

ArticleChemical communications (Cambridge, England)2018

Sterol-modified PEG lipids: alteration of the bilayer anchoring moiety has an unexpected effect on liposome circulation.

Aaron Dolor, Paul Kierstead, Zhipeng Dai, Francis C Szoka

Erratum issuedAbstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Aaron DolorPharmaceutical Sciences and Pharmacogenomics Graduate Program, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, 94143, USA. Frank.szoka@ucsf.edu.
Paul KiersteadTricida Inc, South, San Francisco, California, USA.
Zhipeng DaiZoneOne Pharma Inc., San Francisco, California, USA and Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, 94143, USA.ORCID http://orcid.org/0000-0003-4716-3096
Francis C SzokaPharmaceutical Sciences and Pharmacogenomics Graduate Program, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, 94143, USA. Frank.szoka@ucsf.edu.ORCID http://orcid.org/0000-0002-6236-0621

Funding

PHARMACEUTICAL SCIENCES AND PHARMACOGENOMICST32GM007175 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AHITUV, NADAV, KROETZ, DEANNA L · 1985 to 2021
$7.1M
NIGMS NIH HHS T32 GM007175
6 · The paper itself

Abstract

We synthesized and characterized two novel sterol-anchored polyethylene glycols (PEG) as potential alternatives to conventional phosphatidylethanolamine-PEGs. Liposomes containing the dicholesterol anchored PEG at 5 mole percent exhibit canonical PEGgylated-liposome behaviors including retention of encapsulated small molecules, low serum protein adsorption, and reduced cellular uptake yet they do not exhibit long circulation.

Indexed as

Lipid BilayersLipidsLiposomesMicroscopy, Electron, TransmissionMolecular StructurePolyethylene GlycolsSterolsLipid BilayersLipidsLiposomespolyethylene glycol 400Polyethylene GlycolsSterols

Identifiers

PMID30288531
PMCPMC6764448

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.